{"gene":"PF3D7_1251300","run_date":"2026-09-08T14:19:06","timeline":{"discoveries":[{"year":2008,"finding":"Recombinant P. falciparum TMK (PfTMK) expressed in E. coli is a homodimer that phosphorylates dTMP and dUMP and, uniquely among thymidylate kinases, also accepts bulkier purine substrates dGMP, GMP, and dIMP. Km values for TMP and dGMP are 22 and 30 µM respectively; kcat for TMP is 3.4 s⁻¹. The enzyme shows maximal activity over pH 7–9 and marked thermostability.","method":"Heterologous expression in E. coli, steady-state kinetic analysis, initial velocity studies","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant enzyme with kinetic characterization and multiple substrates tested in a single lab, single publication","pmids":["18477629"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Active-site mutagenesis of P. falciparum TMK showed that the A111K substitution markedly reduced kinase activity, and the Y107F mutation abolished the hydroxyl group contact required for catalysis, with a more severe impact on dGMP kinase activity than on TMP kinase activity. Thermodynamic (ITC) analysis revealed that enthalpic forces govern binding of both TMP and dGMP, with comparable overall binding affinities but lower heat produced for dGMP, indicating additional interactions occur with TMP that are lost with the larger purine substrate.","method":"Site-directed mutagenesis, isothermal titration calorimetry (ITC), kinetic assays","journal":"Parasitology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis combined with ITC thermodynamics in a single lab study","pmids":["19126267"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"Crystal structures of P. falciparum TMK in ternary complexes (dTMP-ADP and AZT-MP-ADP) and a binary complex with transition-state analogue AP5dT revealed the structural basis for efficient phosphorylation of AZT-MP: the P-loop and lid region adopt a conformation in which the azide of AZT-MP faces no steric conflicts, requiring no further P-loop movement to reach the transition state, in contrast to the human enzyme. These structures also explain the unique ability to accept dGMP as a substrate through a broader active-site architecture compared with human TMPK.","method":"X-ray crystallography (ternary and binary complexes), kinetic analysis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal structures with functional interpretation by kinetics, replicated by structural validation of two ternary complexes plus transition-state analogue complex","pmids":["20353400"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"P. falciparum TMK efficiently phosphorylates AZT-MP (kinetics comparable to the E. coli type II enzyme) and can activate prodrug analogues of AZT at the monophosphate level. The parasite lacks a pyrimidine nucleoside kinase, so TMK serves as the entry point for nucleoside analogue activation to the monophosphate in the de novo pyrimidine pathway.","method":"Enzyme kinetics with recombinant PfTMK, prodrug cell-based antiparasitic assays","journal":"Bioorganic & medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinetic demonstration of substrate acceptance combined with cell-based prodrug activity, single lab","pmids":["20833052"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"ITC competition binding experiments showed that dGMP cannot displace TMP from the PfTMK active site, whereas TMP can partially displace dGMP with reduced affinity, indicating that TMP and dGMP share overlapping but distinct binding sites with TMP binding more tightly and exhibiting higher enthalpic interactions.","method":"Isothermal titration calorimetry (ITC) competition binding","journal":"Biological & pharmaceutical bulletin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ITC competition binding experiments, single lab, single method","pmids":["21212540"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"finding":"Crystal structures of PfTMK in complex with α- and β-thymidine urea-derivative inhibitors were solved, revealing the structural basis for inhibitor binding and demonstrating that certain 5'-urea-α-thymidine analogues inhibit parasite growth primarily through an off-target mechanism rather than PfTMK inhibition.","method":"X-ray crystallography of enzyme-inhibitor complexes, enzymatic inhibition assays, parasite growth assays","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — crystal structures plus cell-based assays, single lab; the off-target conclusion is supported by structural and cellular data together","pmids":["23240776"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"Mutagenesis combined with docking simulations mapped the binding site of α-thymidine urea-derivative inhibitors on PfTMK. Measured Ki and KD values for these compounds were significantly weaker than their reported EC50 for parasite growth inhibition, indicating that parasite growth inhibition by these compounds is predominantly due to an off-target effect rather than PfTMK inhibition.","method":"Site-directed mutagenesis, enzyme inhibition assays (Ki determination), binding affinity measurement (KD), molecular docking","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis plus binding characterization in single lab, two orthogonal methods (kinetics and affinity), confirms off-target mechanism","pmids":["29684273"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"finding":"NMR relaxation dispersion and ITC studies showed that dGMP binding to the PfTMK homodimer exhibits a unique half-site binding mechanism (negative cooperativity), with the second protomer's active site occluded after initial dGMP binding. The dGMP-enzyme complex is more conformationally dynamic at the dimer interface than the TMP-enzyme complex on the µs–ms timescale. Mutational studies identified residues contributing to the unique capacity to utilize dGMP as a substrate.","method":"Isothermal titration calorimetry, tryptophan fluorescence titration, NMR relaxation dispersion, molecular mechanics calculations, site-directed mutagenesis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (ITC, NMR, fluorescence, mutagenesis, MD) in a single rigorous study establishing the half-site mechanism and dimer interface dynamics","pmids":["31934749"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"P. falciparum TMK (PfTMK/PF3D7_1251300) is a homodimeric type I thymidylate kinase that catalyzes phosphorylation of TMP to TDP using an enthalpically driven mechanism; unlike its human counterpart, it accepts dGMP as a substrate with comparable affinity to TMP (though via a unique half-site negative-cooperativity binding mechanism and with greater dimer-interface dynamics), efficiently phosphorylates AZT-MP through a P-loop/lid geometry that avoids steric conflict with the azide group, and serves as the parasite's entry point for nucleoside analogue activation given the absence of a pyrimidine nucleoside kinase; active-site residues Y107 and A111 are critical for catalysis and substrate discrimination, and TMP outcompetes dGMP at the shared active site."},"narrative":{"mechanistic_narrative":"PF3D7_1251300 (TMK) is the Plasmodium falciparum thymidylate kinase, a homodimeric enzyme that phosphorylates dTMP to the diphosphate and, uniquely among thymidylate kinases, also accepts the bulkier purine substrates dGMP, GMP, and dIMP with affinity comparable to that for TMP [PMID:18477629]. Crystallographic and thermodynamic analyses show a broader active-site architecture than the human enzyme: enthalpic forces govern binding of both TMP and dGMP, TMP forms additional interactions that dGMP lacks, and the active-site residues Y107 and A111 are critical for catalysis and substrate discrimination, with Y107F disproportionately impairing dGMP over TMP turnover [PMID:19126267, PMID:20353400]. TMP and dGMP occupy overlapping but distinct sites in which TMP binds more tightly and cannot be displaced by dGMP, and dGMP binding to the homodimer proceeds by a half-site negative-cooperativity mechanism with heightened dimer-interface dynamics [PMID:21212540, PMID:31934749]. Because the parasite lacks a pyrimidine nucleoside kinase, TMK is the entry point for activating nucleoside-analogue prodrugs, and a P-loop/lid geometry that avoids steric conflict with the azide group allows it to efficiently phosphorylate AZT-MP, positioning it as an antimalarial drug target [PMID:20353400, PMID:20833052]. Structural and mutagenesis work on thymidine-urea inhibitors established that their antiparasitic activity arises predominantly from an off-target effect rather than direct TMK inhibition [PMID:23240776, PMID:29684273].","teleology":[{"year":2008,"claim":"Establishing that the recombinant parasite enzyme is a homodimeric thymidylate kinase with an unusually broad substrate range answered whether P. falciparum TMK differs functionally from canonical thymidylate kinases.","evidence":"Heterologous expression in E. coli with steady-state kinetics on TMP, dUMP, dGMP, GMP, and dIMP","pmids":["18477629"],"confidence":"Medium","gaps":["Physiological relevance of purine-monophosphate phosphorylation in the parasite not established","No structural basis for broad specificity at this stage"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Mutagenesis and calorimetry defined which active-site residues drive catalysis and how the enzyme energetically accommodates two chemically distinct substrates.","evidence":"Site-directed mutagenesis (Y107F, A111K) plus ITC and kinetic assays on TMP and dGMP","pmids":["19126267"],"confidence":"Medium","gaps":["Full residue map of the dGMP-specificity determinants not resolved","Kinetic mechanism of catalysis not defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"Crystal structures explained the structural basis for both broad substrate acceptance and efficient AZT-MP phosphorylation, framing the enzyme as a rationally targetable drug-activation node.","evidence":"X-ray structures of ternary (dTMP-ADP, AZT-MP-ADP) and binary AP5dT complexes with kinetic interpretation","pmids":["20353400","20833052"],"confidence":"High","gaps":["In vivo essentiality of TMK not tested genetically","Prodrug activation shown biochemically and in cell assays but not validated in animal infection"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"claim":"Competition binding resolved how TMP and dGMP share the active site, showing TMP is the preferred, more tightly bound ligand.","evidence":"ITC competition binding experiments with TMP and dGMP","pmids":["21212540"],"confidence":"Medium","gaps":["Consequence of substrate competition for nucleotide-pool homeostasis in the parasite unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Combined structural, mutagenesis, and affinity work with thymidine-urea inhibitors clarified that their antiparasitic activity is largely off-target, an important caution for TMK-directed drug discovery.","evidence":"Enzyme-inhibitor crystal structures, mutagenesis, Ki/KD determination, docking, and parasite growth assays","pmids":["23240776","29684273"],"confidence":"Medium","gaps":["The actual off-target(s) responsible for growth inhibition not identified","No validated on-target TMK inhibitor established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"claim":"Dynamic and thermodynamic profiling revealed a half-site negative-cooperativity mechanism for dGMP binding, explaining how the homodimer manages purine substrate handling.","evidence":"ITC, tryptophan fluorescence, NMR relaxation dispersion, molecular mechanics, and mutagenesis on the PfTMK dimer","pmids":["31934749"],"confidence":"High","gaps":["Functional/biological significance of half-site behavior in the parasite unknown","Whether negative cooperativity also governs the physiological TMP reaction not resolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"Whether TMK is genetically essential in P. falciparum and can be selectively targeted in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No genetic knockout/knockdown data in the corpus","No validated on-target inhibitor with in vivo efficacy","In vivo prodrug-activation role not confirmed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["Homodimer"],"partners":[],"other_free_text":["Uniquely accepts purine monophosphates (dGMP, GMP, dIMP) in addition to dTMP/dUMP [#0]","Catalytic/specificity residues Y107 and A111; Y107F abolishes hydroxyl contact required for catalysis [#1]","Enthalpically driven substrate binding; TMP forms additional interactions relative to dGMP [#1, #4]","Half-site negative-cooperativity binding of dGMP with heightened dimer-interface dynamics [#7]","Entry point for nucleoside-analogue (AZT-MP) activation due to absence of a parasite pyrimidine nucleoside kinase [#3]","P-loop/lid geometry avoids steric conflict with the AZT azide group, enabling efficient AZT-MP phosphorylation [#2]","Thymidine-urea inhibitors inhibit parasite growth predominantly via an off-target mechanism, not direct TMK inhibition [#5, #6]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"20353400","id":"PMC_20353400","title":"Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20353400","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23240776","id":"PMC_23240776","title":"Synthesis and evaluation of α-thymidine analogues as novel antimalarials.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23240776","citation_count":30,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19126267","id":"PMC_19126267","title":"Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery.","date":"2009","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/19126267","citation_count":29,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18477629","id":"PMC_18477629","title":"Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.","date":"2008","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18477629","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20833052","id":"PMC_20833052","title":"Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum.","date":"2010","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20833052","citation_count":14,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38127294","id":"PMC_38127294","title":"Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds.","date":"2023","source":"Molecular diversity","url":"https://pubmed.ncbi.nlm.nih.gov/38127294","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["TMK"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23850534","id":"PMC_23850534","title":"First report on exploring structural requirements of α and β thymidine analogs for PfTMPK inhibitory activity using in silico studies.","date":"2013","source":"Bio Systems","url":"https://pubmed.ncbi.nlm.nih.gov/23850534","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19749249","id":"PMC_19749249","title":"The exceptional properties of Plasmodium deoxyguanylate pathways as a potential area for metabolic and drug discovery studies.","date":"2009","source":"Nucleic acids symposium series (2004)","url":"https://pubmed.ncbi.nlm.nih.gov/19749249","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22425904","id":"PMC_22425904","title":"Carbocyclic thymidine derivatives efficiently inhibit Plasmodium falciparum thymidylate kinase (PfTMK).","date":"2012","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/22425904","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21212540","id":"PMC_21212540","title":"The substrate binding preferences of Plasmodium thymidylate kinase.","date":"2011","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/21212540","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19749371","id":"PMC_19749371","title":"Thymidylate kinase: the lost chemotherapeutic target.","date":"2009","source":"Nucleic acids symposium series (2004)","url":"https://pubmed.ncbi.nlm.nih.gov/19749371","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23583697","id":"PMC_23583697","title":"Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase.","date":"2013","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/23583697","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29684273","id":"PMC_29684273","title":"Interaction of α-Thymidine Inhibitors with Thymidylate Kinase from Plasmodium falciparum.","date":"2018","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29684273","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30730992","id":"PMC_30730992","title":"The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30730992","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["TMK","thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31934749","id":"PMC_31934749","title":"dGMP Binding to Thymidylate Kinase from Plasmodium falciparum Shows Half-Site Binding and Induces Protein Dynamics at the Dimer Interface.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31934749","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["thymidylate kinase"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9095,"output_tokens":2377,"usd":0.03147,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7876,"output_tokens":2841,"usd":0.055203,"stage2_stop_reason":"end_turn"},"total_usd":0.086673,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"Recombinant P. falciparum TMK (PfTMK) expressed in E. coli is a homodimer that phosphorylates dTMP and dUMP and, uniquely among thymidylate kinases, also accepts bulkier purine substrates dGMP, GMP, and dIMP. Km values for TMP and dGMP are 22 and 30 µM respectively; kcat for TMP is 3.4 s⁻¹. The enzyme shows maximal activity over pH 7–9 and marked thermostability.\",\n      \"method\": \"Heterologous expression in E. coli, steady-state kinetic analysis, initial velocity studies\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant enzyme with kinetic characterization and multiple substrates tested in a single lab, single publication\",\n      \"pmids\": [\"18477629\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Active-site mutagenesis of P. falciparum TMK showed that the A111K substitution markedly reduced kinase activity, and the Y107F mutation abolished the hydroxyl group contact required for catalysis, with a more severe impact on dGMP kinase activity than on TMP kinase activity. Thermodynamic (ITC) analysis revealed that enthalpic forces govern binding of both TMP and dGMP, with comparable overall binding affinities but lower heat produced for dGMP, indicating additional interactions occur with TMP that are lost with the larger purine substrate.\",\n      \"method\": \"Site-directed mutagenesis, isothermal titration calorimetry (ITC), kinetic assays\",\n      \"journal\": \"Parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis combined with ITC thermodynamics in a single lab study\",\n      \"pmids\": [\"19126267\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of P. falciparum TMK in ternary complexes (dTMP-ADP and AZT-MP-ADP) and a binary complex with transition-state analogue AP5dT revealed the structural basis for efficient phosphorylation of AZT-MP: the P-loop and lid region adopt a conformation in which the azide of AZT-MP faces no steric conflicts, requiring no further P-loop movement to reach the transition state, in contrast to the human enzyme. These structures also explain the unique ability to accept dGMP as a substrate through a broader active-site architecture compared with human TMPK.\",\n      \"method\": \"X-ray crystallography (ternary and binary complexes), kinetic analysis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal structures with functional interpretation by kinetics, replicated by structural validation of two ternary complexes plus transition-state analogue complex\",\n      \"pmids\": [\"20353400\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"P. falciparum TMK efficiently phosphorylates AZT-MP (kinetics comparable to the E. coli type II enzyme) and can activate prodrug analogues of AZT at the monophosphate level. The parasite lacks a pyrimidine nucleoside kinase, so TMK serves as the entry point for nucleoside analogue activation to the monophosphate in the de novo pyrimidine pathway.\",\n      \"method\": \"Enzyme kinetics with recombinant PfTMK, prodrug cell-based antiparasitic assays\",\n      \"journal\": \"Bioorganic & medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinetic demonstration of substrate acceptance combined with cell-based prodrug activity, single lab\",\n      \"pmids\": [\"20833052\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ITC competition binding experiments showed that dGMP cannot displace TMP from the PfTMK active site, whereas TMP can partially displace dGMP with reduced affinity, indicating that TMP and dGMP share overlapping but distinct binding sites with TMP binding more tightly and exhibiting higher enthalpic interactions.\",\n      \"method\": \"Isothermal titration calorimetry (ITC) competition binding\",\n      \"journal\": \"Biological & pharmaceutical bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ITC competition binding experiments, single lab, single method\",\n      \"pmids\": [\"21212540\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structures of PfTMK in complex with α- and β-thymidine urea-derivative inhibitors were solved, revealing the structural basis for inhibitor binding and demonstrating that certain 5'-urea-α-thymidine analogues inhibit parasite growth primarily through an off-target mechanism rather than PfTMK inhibition.\",\n      \"method\": \"X-ray crystallography of enzyme-inhibitor complexes, enzymatic inhibition assays, parasite growth assays\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures plus cell-based assays, single lab; the off-target conclusion is supported by structural and cellular data together\",\n      \"pmids\": [\"23240776\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mutagenesis combined with docking simulations mapped the binding site of α-thymidine urea-derivative inhibitors on PfTMK. Measured Ki and KD values for these compounds were significantly weaker than their reported EC50 for parasite growth inhibition, indicating that parasite growth inhibition by these compounds is predominantly due to an off-target effect rather than PfTMK inhibition.\",\n      \"method\": \"Site-directed mutagenesis, enzyme inhibition assays (Ki determination), binding affinity measurement (KD), molecular docking\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis plus binding characterization in single lab, two orthogonal methods (kinetics and affinity), confirms off-target mechanism\",\n      \"pmids\": [\"29684273\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NMR relaxation dispersion and ITC studies showed that dGMP binding to the PfTMK homodimer exhibits a unique half-site binding mechanism (negative cooperativity), with the second protomer's active site occluded after initial dGMP binding. The dGMP-enzyme complex is more conformationally dynamic at the dimer interface than the TMP-enzyme complex on the µs–ms timescale. Mutational studies identified residues contributing to the unique capacity to utilize dGMP as a substrate.\",\n      \"method\": \"Isothermal titration calorimetry, tryptophan fluorescence titration, NMR relaxation dispersion, molecular mechanics calculations, site-directed mutagenesis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (ITC, NMR, fluorescence, mutagenesis, MD) in a single rigorous study establishing the half-site mechanism and dimer interface dynamics\",\n      \"pmids\": [\"31934749\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"P. falciparum TMK (PfTMK/PF3D7_1251300) is a homodimeric type I thymidylate kinase that catalyzes phosphorylation of TMP to TDP using an enthalpically driven mechanism; unlike its human counterpart, it accepts dGMP as a substrate with comparable affinity to TMP (though via a unique half-site negative-cooperativity binding mechanism and with greater dimer-interface dynamics), efficiently phosphorylates AZT-MP through a P-loop/lid geometry that avoids steric conflict with the azide group, and serves as the parasite's entry point for nucleoside analogue activation given the absence of a pyrimidine nucleoside kinase; active-site residues Y107 and A111 are critical for catalysis and substrate discrimination, and TMP outcompetes dGMP at the shared active site.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PF3D7_1251300 (TMK) is the Plasmodium falciparum thymidylate kinase, a homodimeric enzyme that phosphorylates dTMP to the diphosphate and, uniquely among thymidylate kinases, also accepts the bulkier purine substrates dGMP, GMP, and dIMP with affinity comparable to that for TMP [#0]. Crystallographic and thermodynamic analyses show a broader active-site architecture than the human enzyme: enthalpic forces govern binding of both TMP and dGMP, TMP forms additional interactions that dGMP lacks, and the active-site residues Y107 and A111 are critical for catalysis and substrate discrimination, with Y107F disproportionately impairing dGMP over TMP turnover [#1, #2]. TMP and dGMP occupy overlapping but distinct sites in which TMP binds more tightly and cannot be displaced by dGMP, and dGMP binding to the homodimer proceeds by a half-site negative-cooperativity mechanism with heightened dimer-interface dynamics [#4, #7]. Because the parasite lacks a pyrimidine nucleoside kinase, TMK is the entry point for activating nucleoside-analogue prodrugs, and a P-loop/lid geometry that avoids steric conflict with the azide group allows it to efficiently phosphorylate AZT-MP, positioning it as an antimalarial drug target [#2, #3]. Structural and mutagenesis work on thymidine-urea inhibitors established that their antiparasitic activity arises predominantly from an off-target effect rather than direct TMK inhibition [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Establishing that the recombinant parasite enzyme is a homodimeric thymidylate kinase with an unusually broad substrate range answered whether P. falciparum TMK differs functionally from canonical thymidylate kinases.\",\n      \"evidence\": \"Heterologous expression in E. coli with steady-state kinetics on TMP, dUMP, dGMP, GMP, and dIMP\",\n      \"pmids\": [\"18477629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of purine-monophosphate phosphorylation in the parasite not established\", \"No structural basis for broad specificity at this stage\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mutagenesis and calorimetry defined which active-site residues drive catalysis and how the enzyme energetically accommodates two chemically distinct substrates.\",\n      \"evidence\": \"Site-directed mutagenesis (Y107F, A111K) plus ITC and kinetic assays on TMP and dGMP\",\n      \"pmids\": [\"19126267\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full residue map of the dGMP-specificity determinants not resolved\", \"Kinetic mechanism of catalysis not defined\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Crystal structures explained the structural basis for both broad substrate acceptance and efficient AZT-MP phosphorylation, framing the enzyme as a rationally targetable drug-activation node.\",\n      \"evidence\": \"X-ray structures of ternary (dTMP-ADP, AZT-MP-ADP) and binary AP5dT complexes with kinetic interpretation\",\n      \"pmids\": [\"20353400\", \"20833052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo essentiality of TMK not tested genetically\", \"Prodrug activation shown biochemically and in cell assays but not validated in animal infection\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Competition binding resolved how TMP and dGMP share the active site, showing TMP is the preferred, more tightly bound ligand.\",\n      \"evidence\": \"ITC competition binding experiments with TMP and dGMP\",\n      \"pmids\": [\"21212540\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Consequence of substrate competition for nucleotide-pool homeostasis in the parasite unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Combined structural, mutagenesis, and affinity work with thymidine-urea inhibitors clarified that their antiparasitic activity is largely off-target, an important caution for TMK-directed drug discovery.\",\n      \"evidence\": \"Enzyme-inhibitor crystal structures, mutagenesis, Ki/KD determination, docking, and parasite growth assays\",\n      \"pmids\": [\"23240776\", \"29684273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The actual off-target(s) responsible for growth inhibition not identified\", \"No validated on-target TMK inhibitor established\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Dynamic and thermodynamic profiling revealed a half-site negative-cooperativity mechanism for dGMP binding, explaining how the homodimer manages purine substrate handling.\",\n      \"evidence\": \"ITC, tryptophan fluorescence, NMR relaxation dispersion, molecular mechanics, and mutagenesis on the PfTMK dimer\",\n      \"pmids\": [\"31934749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional/biological significance of half-site behavior in the parasite unknown\", \"Whether negative cooperativity also governs the physiological TMP reaction not resolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether TMK is genetically essential in P. falciparum and can be selectively targeted in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genetic knockout/knockdown data in the corpus\", \"No validated on-target inhibitor with in vivo efficacy\", \"In vivo prodrug-activation role not confirmed\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004798\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0005524\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006231\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0006220\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"complexes\": [\"Homodimer\"],\n    \"partners\": [],\n    \"other_free_text\": [\n      \"Uniquely accepts purine monophosphates (dGMP, GMP, dIMP) in addition to dTMP/dUMP [#0]\",\n      \"Catalytic/specificity residues Y107 and A111; Y107F abolishes hydroxyl contact required for catalysis [#1]\",\n      \"Enthalpically driven substrate binding; TMP forms additional interactions relative to dGMP [#1, #4]\",\n      \"Half-site negative-cooperativity binding of dGMP with heightened dimer-interface dynamics [#7]\",\n      \"Entry point for nucleoside-analogue (AZT-MP) activation due to absence of a parasite pyrimidine nucleoside kinase [#3]\",\n      \"P-loop/lid geometry avoids steric conflict with the AZT azide group, enabling efficient AZT-MP phosphorylation [#2]\",\n      \"Thymidine-urea inhibitors inhibit parasite growth predominantly via an off-target mechanism, not direct TMK inhibition [#5, #6]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1251300","name":null,"product":"thymidylate kinase","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1464200","name":null,"product":"thymidylate kinase, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1471300","name":null,"product":"thymidylate kinase, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"TMK","evaluation":null}